Ney Carter Borges/LinkedIn
Apr 2, 2026, 16:08
Ney Carter Borges: Early Surgery vs Conservative Care in Asymptomatic Very Severe Aortic Stenosis
Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared a post on LinkedIn:
”Early surgery vs conservative care in asymptomatic very severe aortic stenosis (10-year outcomes)
Key findings (Recovery Trial – 10-Year Follow-up)
Population:
Asymptomatic patients with very severe aortic stenosis
(AVA ≤0.75 cm², Vmax ≥4.5 m/s)
Primary Outcome (CV death or operative mortality):
- Early Surgery: 3%
- Conservative Care: 24%
- HR 0.10 (95% CI 0.02–0.43; p=0.002)
All-Cause Mortality:
- Early Surgery: 15%
- Conservative Care: 32%
- HR 0.42 (95% CI 0.21–0.86)
Heart Failure Hospitalization:
- Early Surgery: 0%
- Conservative Care: 19%
Number Needed to Treat (10 years):
- NNT ≈ 6 (CV death)
- NNT ≈ 7 (all-cause death)
Clinical interpretation
- Early intervention dramatically reduces cardiovascular mortality
- Benefit is sustained over 10 years (no curve convergence)
- Conservative strategy leads to:
- Delayed surgery
- Higher HF burden
- Increased pre-operative risk
- Key insight: ‘Waiting for symptoms may allow irreversible myocardial damage’
Practice-changing message
In carefully selected asymptomatic patients with very severe AS, early surgical AVR should be strongly considered, especially when:
- Low surgical risk
- High transvalvular velocity
- Evidence of disease progression.”

Other posts featuring Net Carter Borges on Hemostasis Today.
-
Oct 4, 2026, 15:06Vasiliki Gkalea: Journal of Clinical Medicine Launches Special Issue on Hematologic Thrombosis and Bleeding
-
Oct 4, 2026, 14:55Quentin Brebant: What Defines a High-Quality Red Blood Cell Concentrate?
-
Oct 4, 2026, 14:47Rana Al-Hrout: Recognizing Non-Anemic Iron Deficiency – Why Iron Matters Beyond Hemoglobin
-
Oct 4, 2026, 14:41David McIntosh: International Plasma Awareness Week 2026 – Closing the Global Plasma Gap
-
Oct 4, 2026, 14:33Pete Stibbs: CleanerVac Real-World Study Presented at VIVA and The VEINS 2026
-
Oct 4, 2026, 13:56Maria Elisa Mancuso: EHC 2026 Highlights the Unmet Needs of Women with Bleeding Disorders
-
Oct 4, 2026, 13:53Nirmal Shaji George: Individualizing Anticoagulation in Complex APS and Thrombocytopenia
-
Oct 4, 2026, 13:5210 Posts Not to Miss This Week
-
Oct 4, 2026, 13:45Suswapna Singh Rawat: The Clinical Significance of Coronary Plaque Stability